Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Autor: Ossenkoppele, Gert, Pagoni, Maria N., Söderlund, Stina, Escoffre-Barbe, Martine, Etienne, Gabriel, Dengler, Jolanta, Huguet, Francoise, von Bubnoff, Nikolas, Klamova, Hana, Faber, Edgar, Guilhot, Francois, Lotfi, Kourosh, Rea, Delphine, Brümmendorf, Tim H., de Greef, Gorgine E., Stenke, Leif, Nicolini, Franck E., Legros, Laurence, Burchert, Andreas, Voglova, Jaroslava, Charbonnier, Aude, Gyan, Emmanuel, Kunzmann, Volker, Westerweel, Peter E., Saussele, Susanne ^{a, *}, Richter, Johan ^{b, *}, Guilhot, Joelle ^{c, *}, Gruber, Franz X ^{d, **}, Hjorth-Hansen, Henrik ^e, Almeida, Antonio ^f, Janssen, Jeroen J W M ^g, Mayer, Jiri ^h, Koskenvesa, Perttu ^{i, k}, Panayiotidis, Panayiotis ^l, Olsson-Strömberg, Ulla ^m, Martinez-Lopez, Joaquin ⁿ, Rousselot, Philippe ^o, Vestergaard, Hanne ^p, Ehrencrona, Hans ^{q, r}, Kairisto, Veli ^s, Machová Poláková, Katerina ^t, Müller, Martin C ^u, Mustjoki, Satu ^{i, j, k}, Berger, Marc G ^v, Fabarius, Alice ^a, Hofmann, Wolf-Karsten ^a, Hochhaus, Andreas ^w, Pfirrmann, Markus ^{x, †}, Mahon, Francois-Xavier ^{y, †, *}

Publikováno v: In The Lancet Oncology June 2018 19(6):747-757

The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes

Autor: Basavaraj, Manjunath Goolyam ^{a, ⁎}, Gruber, Franz X. ^b, Sovershaev, Mikhail ^c, Appelbom, Hege I. ^a, Østerud, Bjarne ^d, Petersen, Lars C. ^e, Hansen, John-Bjarne ^a

Publikováno v: In Thrombosis Research July 2010

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and Efficacy of adding pegylated Interferon–α2b to standard Dose Dasatinib in newly diagnosed CP-CML

Autor: Hjort-Hansen, Henrik, Stentoft, Jepser, Richter, Johan, Koskenvesa, Perttu, Söderlund, Stina, Dreimane, Arta, Porkka, Kimmo, Dahl, Tobias Gedde, Gjertsen, Bjørn Tore, Gruber, Franz X, Stenke, Leif, Eriksson, Kristina Myhr, Markevärn, Berit, Vestergaard, Hanne, Udby, Lene, Bjerrum, Ole Weis, Mustjoki, Satu, Olsson-Strömberg, Ulla

Publikováno v: Hjort-Hansen, H, Stentoft, J, Richter, J, Koskenvesa, P, Söderlund, S, Dreimane, A, Porkka, K, Dahl, T G, Gjertsen, B T, Gruber, F X, Stenke, L, Eriksson, K M, Markevärn, B, Vestergaard, H, Udby, L, Bjerrum, O W, Mustjoki, S & Olsson-Strömberg, U 2015, ' Safety and Efficacy of adding pegylated Interferon–α2b to standard Dose Dasatinib in newly diagnosed CP-CML ', 57th American Society of Hematology Annual Meeting and Exposition, Orlando, United States, 04/12/2015-08/12/2015 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::705d2bdef95e4cc8638ab68f3d1384fe
https://findresearcher.sdu.dk:8443/ws/files/118250880/Safety_and_Efficacy_of_adding_pegylated_Interferon_2b_to_standard_Dose_Dasatinib_in_newly_diagnosed_CP_CML.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.